Effectiveness of progressive dose-escalation of exenatide (exendin-4) in reducing dose-limiting side effects in subjects with type 2 diabetes.

MLA

Fineman, Mark S., et al. “Effectiveness of Progressive Dose-Escalation of Exenatide (Exendin-4) in Reducing Dose-Limiting Side Effects in Subjects with Type 2 Diabetes.” Diabetes/Metabolism Research & Reviews, vol. 20, no. 5, Sept. 2004, pp. 411–17. EBSCOhost, https://doi.org/10.1002/dmrr.499.

APA

Fineman, M. S., Shen, L. Z., Taylor, K., Kim, D. D., & Baron, A. D. (2004). Effectiveness of progressive dose-escalation of exenatide (exendin-4) in reducing dose-limiting side effects in subjects with type 2 diabetes. Diabetes/Metabolism Research & Reviews, 20(5), 411–417. https://doi.org/10.1002/dmrr.499

Chicago

Fineman, Mark S., Larry Z. Shen, Kristin Taylor, Dennis D. Kim, and Alain D. Baron. 2004. “Effectiveness of Progressive Dose-Escalation of Exenatide (Exendin-4) in Reducing Dose-Limiting Side Effects in Subjects with Type 2 Diabetes.” Diabetes/Metabolism Research & Reviews 20 (5): 411–17. doi:10.1002/dmrr.499.